Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38937

DLGAP5 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

The DLGAP5 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from human Raji B lymphocytes, designed for loss-of-function studies of the mitotic regulator DLGAP5 (HURP). DLGAP5 is a microtubule-associated protein critical for spindle assembly and chromosome segregation, acting downstream of Ran GTPase and Aurora A kinase and interacting with TPX2 and KIF11. This polyclonal knockout model enables investigation of mitotic processes, cell cycle regulation, and cancer cell proliferation in a B-cell lymphoma context. Suitable for immunofluorescence, western blotting, flow cytometry, and proliferation assays, the cells provide a valuable tool for studying spindle biology and validating therapeutic targets in lymphoma research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    DLGAP5

    Gene Identifier

    NCBI Gene ID 9787

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DLGAP5 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population generated from the human Raji B-lymphocyte cell line, with disruption of the DLGAP5 gene to provide a loss-of-function model. This heterogeneous pool bypasses clonal selection, offering a versatile system to study DLGAP5 (HURP) functions in lymphoid cells. The CRISPR/Cas9-mediated gene disruption enables investigation of mitotic processes and cancer biology without the constraints of single-cell isolation.

Raji is an EBV-positive Burkitt’s lymphoma B lymphocyte line harboring the t(8;14) translocation that drives MYC overexpression. It serves as a well-established model for B-cell lymphoma and antibody production studies. The high proliferative rate and defined genetic background of Raji cells make them particularly suited for examining cell cycle?Crelated genes such as DLGAP5.

DLGAP5 encodes a microtubule-associated protein essential for mitotic spindle assembly and chromosome segregation. It localizes to kinetochore fibers and central spindle, where it stabilizes microtubules in a Ran-GTP?Cdependent manner. Aurora A kinase phosphorylates DLGAP5, promoting interaction with TPX2 and KIF11. Upstream, FOXM1 transcriptionally regulates DLGAP5 expression, while Ran GTPase and Aurora A signaling control its activity. DLGAP5 interacts with importin beta and forms complexes with TPX2 and microtubules, functioning downstream of the Ran?CAurora A signaling axis. Loss of DLGAP5 disrupts mitotic spindle integrity and cell cycle progression.

In Raji cells, DLGAP5 knockout likely compromises mitotic fidelity, potentially inducing cell cycle arrest or apoptosis. DLGAP5 is often overexpressed in cancers including B-cell lymphoma and hepatocellular carcinoma, correlating with poor outcomes. This polyclonal knockout model, therefore, offers a physiologically relevant system to study how DLGAP5-dependent spindle regulation sustains lymphoma cell proliferation, especially under MYC-driven growth conditions. It allows exploration of mitotic vulnerabilities that could be targeted therapeutically.

The DLGAP5 Knockout Raji Polyclonal Cells are amenable to diverse applications, including immunofluorescence microscopy for spindle morphology assessment, western blotting, flow cytometry for cell cycle analysis, RT-qPCR, and proliferation or apoptosis assays. They support research into mitotic spindle assembly, cell cycle regulation, cancer cell proliferation, and drug target validation in B-cell lymphoma models. For additional technical details or custom services, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)